Clincosm LogoSign in Get a demo

pyoderma gangrenosum

Showing 1 - 25 of 25
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pyoderma Gangrenosum Trial in New York (Spesolimab)

Recruiting
  • Pyoderma Gangrenosum
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Oct 16, 2023

Pyoderma Gangrenosum Trial (Platelet rich plasma therapy)

Not yet recruiting
  • Pyoderma Gangrenosum
  • Platelet rich plasma therapy
  • (no location specified)
Aug 2, 2023

Pyoderma Gangrenosum Trial (IFX-1, Placebo)

Not yet recruiting
  • Pyoderma Gangrenosum
  • (no location specified)
Jul 28, 2023

Pyoderma Gangrenosum Trial in Lebanon (Deucravacitinib)

Not yet recruiting
  • Pyoderma Gangrenosum
  • Lebanon, New Hampshire
    Dartmouth-Hitchcock Medical Center
Apr 6, 2023

Disease State in Adult Participants Being Treated With Humira in

Recruiting
  • Pyoderma Gangrenosum
    • Nagoya shi, Aichi, Japan
    • +44 more
    Jan 13, 2023

    Pyoderma Gangrenosum Trial (Hyperbaric oxygen, Control group)

    Not yet recruiting
    • Pyoderma Gangrenosum
    • Hyperbaric oxygen
    • Control group
    • (no location specified)
    Jul 14, 2022

    Pyoderma, Pyoderma Gangrenosum, Pyoderma Vegetans Trial in Minsk, Riga (Monoclonal antibody (Mab) sB24M)

    Active, not recruiting
    • Pyoderma
    • +3 more
    • Monoclonal antibody (Mab) sB24M
    • Minsk, Belarus
    • +1 more
    Jul 8, 2022

    Pyoderma Gangrenosum Trial in Gahanna (Ixekizumab)

    Completed
    Has Results
    • Pyoderma Gangrenosum
    • Ixekizumab
    • Gahanna, Ohio
      The Ohio State University Dermatology
    May 11, 2022

    JAK-STAT Signaling Pathway in Pyoderma Gangrenosum

    Not yet recruiting
    • Pyoderma Gangrenosum
    • +2 more
    • immunohistochemical methods
    • (no location specified)
    Mar 21, 2022

    Pyoderma Gangrenosum Trial in Stanford (Humira)

    Withdrawn
    • Pyoderma Gangrenosum
    • Stanford, California
      Stanford University
    Feb 3, 2022

    Pyoderma Gangrenosum Trial in Metairie, New Orleans (Dehydrated human amnion/chorion membrane)

    Recruiting
    • Pyoderma Gangrenosum
    • Dehydrated human amnion/chorion membrane
    • Metairie, Louisiana
    • +2 more
    Nov 9, 2021

    Pyoderma Gangrenosum, Skin Diseases, Wound Heal Trial in Portland (Baricitinib)

    Recruiting
    • Pyoderma Gangrenosum
    • +4 more
    • Portland, Oregon
      Oregon Health and Science University
    Sep 8, 2021

    Pyoderma Gangrenosum Trial (secukinumab 150 mg (2 injections per dose)

    Withdrawn
    • Pyoderma Gangrenosum
    • secukinumab 150 mg (2 injections per dose
    • (no location specified)
    May 25, 2021

    Pyoderma Gangrenosum Trial in Japan (adalimumab)

    Completed
    • Pyoderma Gangrenosum
    • Nagoya-shi, Aichi, Japan
    • +19 more
    Mar 5, 2021

    Pyoderma Gangrenosum Trial in Tallahassee (Xilonix)

    Completed
    • Pyoderma Gangrenosum
    • Xilonix
    • Tallahassee, Florida
      XBiotech Investigative Site
    Jan 26, 2021

    Pyoderma Gangrenosum Trial in Munich (Secukinumab)

    Unknown status
    • Pyoderma Gangrenosum
    • Munich, Germany
      Technical University of Munich
    Feb 17, 2020

    Pyoderma Gangrenosum Trial in Winston-Salem (adalimumab)

    Withdrawn
    • Pyoderma Gangrenosum
    • Winston-Salem, North Carolina
      Wake Forest University Health Sciences Dermatology
    Dec 17, 2019

    Comorbidities and Pathologies Associated With Pyoderma

    Unknown status
    • Pyoderma Gangrenosum
    • pathology associated
    • Marseille, Paca, France
      Assistance Publique Des Hopitaux de Marseille
    Aug 17, 2018

    Pyoderma Gangrenosum, Crohn's Disease, Ulcerative Colitis Trial in Cleveland (Infliximab)

    Completed
    Has Results
    • Pyoderma Gangrenosum
    • +3 more
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center
    Sep 27, 2016

    Genetic Architecture of Neutrophil-Mediated Inflammatory Skin

    Unknown status
    • Other Specified Inflammatory Disorders of Skin or Subcutaneous Tissue
    • +27 more
    • Collection of biological samples
    • Zurich, ZH, Switzerland
      University Hospital Zurich, Dept. of Dermatology
    Sep 26, 2016

    Pyoderma Gangrenosum Trial in Zurich (Canakinumab)

    Completed
    • Pyoderma Gangrenosum
    • Zurich, Switzerland
      Department of Dermatology, University Hospital Zurich
    Sep 26, 2016

    Pyoderma Gangrenosum Trial in Australia, Canada, United States (gevokizumab)

    Terminated
    • Pyoderma Gangrenosum
    • Birmingham, Alabama
    • +39 more
    Apr 25, 2016

    Pyoderma Gangrenosum Trial in United States (gevokizumab, Placebo, gevokizumab open-label)

    Terminated
    • Pyoderma Gangrenosum
    • Coral Gables, Florida
    • +11 more
    Apr 25, 2016

    Pyoderma Gangrenosum Trial in Australia, Canada, United States (gevokizumab, Placebo, gevokizumab open-label)

    Terminated
    • Pyoderma Gangrenosum
    • Oceanside, California
    • +15 more
    Apr 25, 2016

    Pyoderma Gangrenosum Trial in United States (gevokizumab)

    Completed
    • Pyoderma Gangrenosum
    • Birmingham, Alabama
    • +18 more
    Feb 2, 2016